<SEC-DOCUMENT>0001193125-17-291495.txt : 20171113
<SEC-HEADER>0001193125-17-291495.hdr.sgml : 20171110
<ACCEPTANCE-DATETIME>20170922171032
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001193125-17-291495
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20170922

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Genprex, Inc.
		CENTRAL INDEX KEY:			0001595248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				900772347
		FISCAL YEAR END:			1213

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		100 CONGRESS AVENUE
		STREET 2:		SUITE 2000
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78701
		BUSINESS PHONE:		512-708-0155

	MAIL ADDRESS:	
		STREET 1:		100 CONGRESS AVENUE
		STREET 2:		SUITE 2000
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78701
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>Correspondence</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:63%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">811 Barton Springs Road </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:63%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Suite 811 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:63%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Austin, Texas 78704 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:63%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">(512) <FONT STYLE="white-space:nowrap">236-9908</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:63%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">(512) <FONT STYLE="white-space:nowrap">236-9904</FONT> (fax) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:63%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">ozburn@slollp.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&nbsp;22, 2017 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">United States Securities and Exchange
Commission </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Corporation Finance </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mail Stop 4546
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">100 F Street, N.E. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Washington, D.C. 20549 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Suzanne Hayes </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Genprex, Inc. </B></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Amendments No.&nbsp;2 and No.&nbsp;3 to Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> </B></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Filed September&nbsp;8, 2017 and September&nbsp;15, 2017 </B></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD ALIGN="left" VALIGN="top"><B>File <FONT STYLE="white-space:nowrap">No.&nbsp;333-219386</FONT> </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Ms.&nbsp;Hayes: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Enclosed on behalf of our client, Genprex, Inc. (the &#147;<B><I>Company</I></B>&#148;), is Amendment No.&nbsp;4 to Registration Statement on
Form <FONT STYLE="white-space:nowrap">S-1</FONT> (&#147;<B><I>Amendment No.</I></B><B><I></I></B><B><I>&nbsp;4</I></B>&#148;). Amendment No.&nbsp;4 updates the Company&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT>
originally filed with the Securities and Exchange Commission (the &#147;<B><I>Commission</I></B>&#148;) on July&nbsp;21, 2017 (the &#147;<B><I>Registration Statement</I></B>&#148;), as amended by Amendment No.&nbsp;1 filed with the Commission on
August&nbsp;18, 2017, by Amendment No.&nbsp;2 filed with the Commission on September&nbsp;8, 2017 and Amendment No.&nbsp;3 filed with the Commission on September&nbsp;15, 2017 (&#147;<B><I>Amendment
No.</I></B><B><I></I></B><B><I>&nbsp;3</I></B>&#148;). The copy of Amendment No.&nbsp;4 that is enclosed with the paper copy of this letter is marked to show changes from Amendment No.&nbsp;3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Amendment No.&nbsp;4 is being submitted in response to a comment received from the staff of the Commission (the
&#147;<B><I>Staff</I></B>&#148;) by letter dated September&nbsp;19, 2017 with respect to the Registration Statement (the &#147;<B><I>Comment Letter</I></B>&#148;) as well as to update the disclosure generally. The numbering of the paragraph below
corresponds to the numbering in the Comment Letter, the text of which we have incorporated into this response letter for convenience. Except where otherwise indicated, page references in the text of the responses below correspond to the page numbers
of the Registration Statement. </P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">United States Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 22, 2017 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Staff Comments and Company Responses </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>General</U> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>1.</I></TD>
<TD ALIGN="left" VALIGN="top"><I>We note the revised disclosure on your cover page that you are offering a minimum of 2,083,334 shares and a maximum of 5,625,000 shares.&nbsp;These amounts conflict with your disclosure throughout that you are
offering a minimum of 2,500,000 shares and a maximum of 4,500,000 shares.&nbsp;We also note your statements that you do not intend to close this offering unless you raise minimum gross proceeds of $12,500,000, and that the disclosure in your fee
table and Escrow Deposition Agreement contemplate a maximum offering amount of $22,500,000.&nbsp;It appears that you are registering a minimum and maximum aggregate offering amount, rather than a minimum and maximum number of shares, which is not
appropriate.&nbsp;Please revise your disclosure throughout the registration statement and your Subscription Agreement and Escrow Deposit Agreement, as necessary, to reflect a set minimum and maximum number of shares to be offered.&nbsp;Refer to Item
501(b)(2) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> and the definition of &#147;amount&#148; in Securities Act Rule 405 for guidance. </I></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Response:</B> In response to the Commission&#146;s comment, the Company has revised the front and back cover pages of the preliminary prospectus included
contained in Amendment No.&nbsp;4, as well as pages 9, 47, 50, 54, 56 and 58 to reflect the change of the estimated initial public offering price from a range to a fixed price and to reflect the corresponding change of the minimum and maximum number
of shares to be offered. The Company has made corresponding revisions to Exhibit 5.1 (Opinion of Streusand, Landon&nbsp;&amp; Ozburn LLP), Exhibit 10.11 (Form of Amended and Restated Escrow Deposit Agreement) and Exhibit 10.19 (Form of Subscription
Agreement). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company respectfully requests the Staff&#146;s assistance in completing the review of Amendment No.&nbsp;4 as soon as
possible. Please advise us if we can provide any further information or assistance to facilitate your review. Please direct any further comments or questions regarding the Amendment or this response letter to me at (512) <FONT
STYLE="white-space:nowrap">236-9908.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Sincerely, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">STREUSAND, LANDON&nbsp;&amp; OZBURN, LLP </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">/s/ Christopher J. Ozburn </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Christopher J. Ozburn </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">cc:</TD>
<TD ALIGN="left" VALIGN="top">J. Rodney Varner, Genprex, Inc. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Philip Magri, Magri Law LLC </TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
